市场调查报告书
商品编码
1297129
数字化糖尿病管理市场规模 - 按产品类型(设备、服务),按患者类型(1型、2型),按终端用户(医院、家庭设置、诊断中心和诊所) - 全球预测至2032年Digital Diabetes Management Market Size - By Product Type (Devices, Services), By Patient Type (Type 1, Type 2), By End-Use (Hospitals, Home Settings, Diagnostic Centers & Clinics) - Global Forecast to 2032 |
全球数字糖尿病管理市场规模将在2032年之前呈指数级增长。对糖尿病的医疗保健支出不断增加是积极影响行业增长的关键因素。全球糖尿病负担的增加,迫使世界各地的许多政府对数字糖尿病管理解决方案进行大量投资,用于远程监测病人。事实上,许多政府也对先进的糖尿病管理设备实施了有利的报销政策,这将进一步塑造行业格局。该领域的商业巨头正强调开发先进的诊断设备,以加强他们的地位,为市场打开新的增长途径。
整个数字糖尿病管理市场根据产品、病人、终端用途和地区进行分类。
在产品方面,数字糖尿病管理设备的市场价值将在2032年之前描绘出可观的收益。糖尿病发生率的上升,加上人们对糖尿病护理的个性化倾向的激增,增加了对数字糖尿病管理设备的需求。此外,这些设备提供了便利和易用性,使个人更简单地监测他们的血糖水平和管理他们的糖尿病日常。
基于病人,1型的行业规模从2023年到2032年将以超过19%的年复合增长率增长。1型糖尿病患病率的激增,增加了数字糖尿病管理解决方案的采用。事实上,用于血糖监测、营养控制、胰岛素滴定和胰岛素输送的移动应用程序在1型糖尿病患者中越来越受欢迎,用于健康跟踪。此外,这一人群高度依赖胰岛素,这增加了胰岛素递送设备的采用。
基于终端用途,诊断中心和诊所部分的行业价值将在2032年之前见证重大收益。先进的胰岛素输送设备的高可用性增加了病人对诊断中心和诊所的访问。许多诊断中心现在提供与数字平台和电子健康记录系统的无缝整合。这种整合允许个人以数字方式接收他们的测试结果,查看一段时间的趋势,并轻松地与他们的医疗保健提供者或数字糖尿病管理应用程序分享数据。
从区域来看,欧洲数字糖尿病管理市场规模到2032年将达到320亿美元。德国、法国、意大利和西班牙等国家的糖尿病发病率不断增长,增加了该地区对数字糖尿病管理解决方案的采用。此外,区域扩张也可归因于领先的行业巨头,如霍夫曼-罗氏有限公司和其他公司强调产品创新以保持其行业地位。
Global Digital Diabetes Management Market size will expand exponentially through 2032. Growing healthcare expenditure towards diabetes is the key factor positively impacting the industry growth. Increasing global burden of diabetes has compelled many governments across the world to invest considerable amounts into digital diabetes management solutions for remote patient monitoring. In fact, many governments have also implemented favorable reimbursement policies for advanced diabetes management devices, which will further shape the industry landscape. Business behemoths in the space are emphasizing developing advanced diagnostic devices to strengthen their position, opening new growth avenues for the market.
The overall digital diabetes management market is categorized based on product, patient, end-use, and region.
In terms of product, digital diabetes management devices market value will depict considerable gains through 2032. Rising occurrence of diabetes, coupled with the surging inclination of people towards a personalized approach to diabetes care, has increased the demand for digital diabetes management devices. Additionally, these devices offer convenience and ease of use, making it simpler for individuals to monitor their blood glucose levels and manage their diabetes daily.
Based on patient, industry size from the type 1 segment will grow at over 19% CAGR from 2023 to 2032. Surging prevalence of type 1 diabetes has increased the adoption of digital diabetes management solutions. In fact, mobile apps for glucose monitoring, nutrition control, insulin titration, and insulin delivery have become increasingly popular among type 1 diabetic people for health tracking. Moreover, this demographic is highly dependent on insulin, which has increased the adoption of insulin-delivery devices.
Based on end-use, industry value from the diagnostic centers & clinics segment will witness significant gains through 2032. High availability of advanced insulin delivery devices has increased patient visits to diagnostic centers & clinics. Many diagnostic centers now offer seamless integration with digital platforms and electronic health record systems. This integration allows individuals to receive their test results digitally, view trends over time, and easily share data with their healthcare providers or digital diabetes management applications.
Regionally, Europe digital diabetes management market size will reach USD 32 billion by 2032. Growing incidence of diabetes in countries such as Germany, France, Italy, and Spain has increased the adoption of digital diabetes management solutions in the region. Moreover, regional expansion can also be attributed to the presence of leading industry giants such as F. Hoffmann-La Roche Ltd and others emphasizing product innovations to retain their industry standing.